Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy may help women with low sexual desire after surgical menopause.

Finasteride can cause serious physical, mental, and sexual side effects, even after stopping the treatment.

Certain medications can reduce sexual desire and function, especially in women.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Hair loss in alopecia areata can negatively affect sexual quality of life.

The document sets criteria for diagnosing long-term sexual dysfunctions caused by certain medications.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Norplant implants lower some androgen levels but don't significantly change sexual function.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

Man experienced lasting sexual dysfunction from finasteride, but malpractice claim was rejected.

Flibanserin may help improve sexual symptoms in various conditions beyond its approved use.

Red ginseng oil improves urinary symptoms and some sexual functions in men safely.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Exogenous testosterone use may be linked to developing hidradenitis suppurativa.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Married Egyptian women with PCOS have lower sexual desire compared to those without PCOS.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Finasteride use may lead to less alcohol consumption in men with lasting sexual side effects.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Primary care doctors should address female sexual dysfunctions to improve women's sexual health and life quality.